HIV-related Kaposi sarcoma: staging and treatment in sub-Saharan Africa
Official title: Project 2
Funded at Lsu Health Sciences Center · NIH-11417962 · Data updated 2026-11-12
A grant focused on improving how we stage and treat HIV-related Kaposi sarcoma, a cancer linked to HIV, especially in sub-Saharan Africa.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $89,210 |
| NIH project number | 5U54CA277846-04 |
| Project ID | NIH-11417962 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV in sub-Saharan Africa who have or are at risk for epidemic Kaposi sarcoma and related malignancies.
✕Less likely to help
Patients with KS not eligible under the study criteria or those without access to ART and chemotherapy options may not benefit.
What this research studies
This project addresses how best to stage and manage epidemic Kaposi sarcoma in people living with HIV. It highlights how tumor extent, immune status, and systemic illness influence outcomes and how ART and chemotherapy can be used together. The work aims to translate established ACTG criteria into practical guidance for care in affected regions. By studying treatment responses, the team hopes to identify approaches that improve survival and quality of life for patients with EpKS.
Why it matters
Potential benefit: If successful, patients with EpKS could receive more accurate staging and more effective, tailored treatment plans.
How similar studies have gone: Previous work shows variable responses to ART alone versus ART plus chemotherapy, with some patients improving while others progress.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Ngalamika, Owen — Lsu Health Sciences Center
- Study coordinator: Ngalamika, Owen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.